Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025)
Siga Technologies (SIGA) posted Change in Accured Expenses of $6.3 million for Q3 2025, up 165.89% on a QoQ basis from -$9.6 million in Q2 2025, and up 728.17% year-over-year from $766720.0 in Q3 2024.
Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Siga Technologies' Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $6.3 million for Q3 2025.
- Quarterly Change in Accured Expenses rose 728.17% year-over-year to $6.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.0 million (up 346.95% YoY) and the FY2024 annual result came in at -$5.7 million, down 387.43% from the prior year.
- Change in Accured Expenses was $6.3 million for Q3 2025 at Siga Technologies, up from -$9.6 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $11.0 million in Q3 2021 and bottomed at -$9.6 million in Q2 2025.
- A 5-year average of $336053.5 and a median of $619665.0 in 2022 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 728.17% in 2025, while the deepest fall reached 906.11% in 2025.
- Siga Technologies' Change in Accured Expenses stood at -$7.6 million in 2021, then soared by 108.13% to $619665.0 in 2022, then soared by 161.02% to $1.6 million in 2023, then sank by 228.58% to -$2.1 million in 2024, then surged by 405.32% to $6.3 million in 2025.
- Business Quant data shows SIGA's Change in Accured Expenses at $6.3 million in Q3 2025, -$9.6 million in Q2 2025, and $10.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.35 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 766,720.00 |
| Sep 30, 2024 | 766,720.00 |
| Jun 30, 2024 | -957,798.00 |
| Jun 30, 2024 | -957,798.00 |
| Mar 31, 2024 | -3.47 Mn |
| Mar 31, 2024 | -3.47 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.93 Mn |